Indian pharma market reflects growth of 7 percent in year 2022
The Indian Pharmaceutical Market (IPM) has reflected growth of 7 percent in the year 2022 with overall IPM market size at Rs 1,93,838 crore Moving Annual Turnover (MAT), as per IQVIA.As per the report, the growth in Sales Value was recorded at 7% (MAT), and Chronic TAs growth (9% MAT) outperformed Acute TAs growth (5% MAT) in 2022.The relative performance of the Indian Pharma companies...
The Indian Pharmaceutical Market (IPM) has reflected growth of 7 percent in the year 2022 with overall IPM market size at Rs 1,93,838 crore Moving Annual Turnover (MAT), as per IQVIA.
As per the report, the growth in Sales Value was recorded at 7% (MAT), and Chronic TAs growth (9% MAT) outperformed Acute TAs growth (5% MAT) in 2022.
The relative performance of the Indian Pharma companies grew faster at 7% compared to MNCs which grew at 4% in 2022. Further, the number of new launches have increased by 2% to 3032 in 2022 as compared to 2021.
For more details, check out the link given below:
Indian Pharma Firms Grew Faster At 7 Percent Compared To 4 Percent Of MNCs In 2022: IQVIA
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd